Correlation Between News Corp and Mereo BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both News Corp and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining News Corp and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between News Corp Cl and Mereo BioPharma Group, you can compare the effects of market volatilities on News Corp and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in News Corp with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of News Corp and Mereo BioPharma.

Diversification Opportunities for News Corp and Mereo BioPharma

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between News and Mereo is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding News Corp Cl and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and News Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on News Corp Cl are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of News Corp i.e., News Corp and Mereo BioPharma go up and down completely randomly.

Pair Corralation between News Corp and Mereo BioPharma

Assuming the 90 days trading horizon News Corp is expected to generate 3.01 times less return on investment than Mereo BioPharma. But when comparing it to its historical volatility, News Corp Cl is 3.13 times less risky than Mereo BioPharma. It trades about 0.07 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  236.00  in Mereo BioPharma Group on August 25, 2024 and sell it today you would earn a total of  136.00  from holding Mereo BioPharma Group or generate 57.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.71%
ValuesDaily Returns

News Corp Cl  vs.  Mereo BioPharma Group

 Performance 
       Timeline  
News Corp Cl 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in News Corp Cl are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, News Corp is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

News Corp and Mereo BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with News Corp and Mereo BioPharma

The main advantage of trading using opposite News Corp and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if News Corp position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.
The idea behind News Corp Cl and Mereo BioPharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Money Managers
Screen money managers from public funds and ETFs managed around the world